The pharma company's shares are getting crushed after regulators decline to green light a drug to treat a rare disease.

Investors profiled retail giants as Adobe predicts a record $10.8 billion in online purchases. Chip and crypto stocks rose, ...

U.S. stocks anticipate a slight rise on Black Friday as the holiday shopping season begins. Retailers are in focus with an ...

Applied Therapeutics' stock plummeted 75 percent after the Food and Drug Administration (FDA) rejected approving govorestat ...

Applied Therapeutics ( APLT, Financials) announced that the U.S. Food and Drug Administration issued a Complete Response ...

German defence giant Rheinmetall and Lithuania on Friday signed deals to begin construction of a $190-million ammunition plant to make artillery shells in the EU and NATO member, which has been ...

Uruguay's ex-president Jose Mujica, who at 89 is an icon for leftists across Latin America, hailed the return of the left to power in his country's weekend elections as a "farewell gift." ...

Applied Therapeutics' (APLT) lead drug candidate, govorestat, likely faces "significant" uncertainty in potentially treating galactosemia after the US Food and Drug Administration rejected the ...

U.S. equities headed to Friday's early close—and the conclusion of November trading—in positive territory as the ...

Applied Therapeutics' New Drug Application for a rare metabolic disease was rejected by the Food and Drug Administration, ...

智通财经APP获悉，周五，Applied Therapeutics ...

近日，Applied Therapeutics Inc.（APLT）在美股盘初下跌76%，创下自其在美国IPO以来最差的盘中表现。这一剧烈波动的原因在于该公司收到了美国食品药品管理局（FDA）的一封“完成反应函”，称其新药申请（NDA）无法按当前格式获得批准。这封信函涉及的是Govorestat药物，指出该申请缺乏必要的临床描述。这一事件不仅对APLT公司造成了巨大的打击，也引发了人们对美国药品监 ...